Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016

Abstract

SummaryBackgroundMonitoring levels and trends in premature mortality is crucial to understanding how societies can address prominent sources of early death. The Global Burden of Disease 2016 Study (GBD 2016) provides a comprehensive assessment of cause-specific mortality for 264 causes in 195 locations from 1980 to 2016. This assessment includes evaluation of the expected epidemiological transition with changes in development and where local patterns deviate from these trends.MethodsWe estimated cause-specific deaths and years of life lost (YLLs) by age, sex, geography, and year. YLLs were calculated from the sum of each death multiplied by the standard life expectancy at each age. We used the GBD cause of death database composed of: vital registration (VR) data corrected for under-registration and garbage coding; national and subnational verbal autopsy (VA) studies corrected for garbage coding; and other sources including surveys and surveillance systems for specific causes such as maternal mortality. To facilitate assessment of quality, we reported on the fraction of deaths assigned to GBD Level 1 or Level 2 causes that cannot be underlying causes of death (major garbage codes) by location and year. Based on completeness, garbage coding, cause list detail, and time periods covered, we provided an overall data quality rating for each location with scores ranging from 0 stars (worst) to 5 stars (best). We used robust statistical methods including the Cause of Death Ensemble model (CODEm) to generate estimates for each location, year, age, and sex. We assessed observed and expected levels and trends of cause-specific deaths in relation to the Socio-demographic Index (SDI), a summary indicator derived from measures of average income per capita, educational attainment, and total fertility, with locations grouped into quintiles by SDI. Relative to GBD 2015, we expanded the GBD cause hierarchy by 18 causes of death for GBD 2016.FindingsThe quality of available data varied by location. Data quality in 25 countries rated in the highest category (5 stars), while 48, 30, 21, and 44 countries were rated at each of the succeeding data quality levels. Vital registration or verbal autopsy data were not available in 27 countries, resulting in the assignment of a zero value for data quality. Deaths from non-communicable diseases (NCDs) represented 72·3% (95% uncertainty interval [UI] 71·2–73·2) of deaths in 2016 with 19·3% (18·5–20·4) of deaths in that year occurring from communicable, maternal, neonatal, and nutritional (CMNN) diseases and a further 8·43% (8·00–8·67) from injuries. Although age-standardised rates of death from NCDs decreased globally between 2006 and 2016, total numbers of these deaths increased; both numbers and age-standardised rates of death from CMNN causes decreased in the decade 2006–16—age-standardised rates of deaths from injuries decreased but total numbers varied little. In 2016, the three leading global causes of death in children under-5 were lower respiratory infections, neonatal preterm birth com...

Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy

“…However, despite numerous phase I and II clinical trials, there is ongoing controversy as to the ideal patient population for cell treatment. Considering that ischemic cardiomyopathy (ICM) is a leading cause of death worldwide and nonischemic dilated cardiomyopathy (DCM) is a progressive disorder with a high morbidity and mortality, often culminating in heart transplant, novel regenerative therapies are required to treat both underlying causes of left ventricular (LV) dysfunction and heart failure (HF) 3. Bone marrow–derived human mesenchymal stem cells (MSCs) are particularly promising because they possess antifibrotic, proangiogenic, and immunomodulatory properties that stimulate repair of damaged tissues 4.…”

Tea Consumption and Longitudinal Change in High‐Density Lipoprotein Cholesterol Concentration in Chinese Adults

“…In 2016, 17.6 million deaths were caused by CVD; the death from cardiovascular diseases increased by 14.5% from 2006 and 2016 1. Previous epidemiological studies suggest that greater tea consumption is related to lower cardiovascular disease (CVD) risk2, 3; 1 to 3 or more cups of green or black tea per day is associated with a 20% to 30% risk reduction in stroke and CVD 3, 4.…”

Estimating mortality from external causes using data from retrospective surveys: A validation study in Niakhar (Senegal)

“…Nevertheless, national levels and trends of mortality from external causes in LMICs are currently extrapolated from these partial data sources (Naghavi et al 2017;Sanghavi, Bhalla, and Das 2009). The resulting estimates may be unreliable because they may omit some deaths, or inaccurately reclassify deaths attributed to unknown causes as injury-related (Bhalla and Harrison 2015).…”